IDIOPATHIC PULMONARY FIBROSIS
Clinical trials for IDIOPATHIC PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common diabetes drug help fight a rare lung disease?
Disease control Not yet recruitingThis study tests whether metformin, a standard diabetes medicine, can slow breathing problems in people with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 400 high-risk participants will receive either metformin or a placebo, and researchers will track who li…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control Not yet recruitingThis study tests whether the experimental drug SYH2059 can help adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing harder. About 156 participants will receive either SYH2059 or a placebo, and researchers will measure changes i…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: InnovStone Therapeutics Limited • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for lung scarring: experimental drug zampilimab enters Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called zampilimab in 240 adults with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. Participants will receive one of two doses of the drug or a placebo for 24 weeks, with an optional 24-week…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
AI model aims to predict lung fibrosis outcomes
Knowledge-focused Not yet recruitingThis study looks at data from 1,000 people with idiopathic pulmonary fibrosis (IPF), a lung disease that gets worse over time. Researchers will use machine learning to find patterns that help predict how the disease will progress. The goal is to create a tool that helps doctors b…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS
Sponsor: University of Modena and Reggio Emilia • Aim: Knowledge-focused
Last updated May 26, 2026 07:59 UTC